Revision to Prior Period Financial Statements (Details) - Schedule of balance sheet and the misstatement	Dec. 17, 2020 USD ($)
As Previously Reported
Balance Sheet
Total assets	$ 59,328,581
Total current liabilities	198,291
Deferred underwriting commissions	2,012,500
Derivative warrant liabilities
Total liabilities	2,210,791
Class A common stock, $0.0001 par value; shares subject to possible redemption	52,117,783
Stockholders’ equity
Preferred stock- $0.0001 par value
Additional paid-in-capital	5,147,829
Accumulated deficit	(148,035)
Total stockholders’ equity	5,000,007
Total liabilities and stockholders’ equity	59,328,581
As Previously Reported | Class B Common Stock
Stockholders’ equity
Common stock value	69
Restatement Adjustment
Balance Sheet
Total assets
Total current liabilities
Derivative warrant liabilities	15,776,805
Total liabilities	15,776,805
Class A common stock, $0.0001 par value; shares subject to possible redemption	(15,776,805)
Stockholders’ equity
Preferred stock- $0.0001 par value
Additional paid-in-capital	3,570,433
Accumulated deficit	(3,570,581)
Total stockholders’ equity
Total liabilities and stockholders’ equity
Restatement Adjustment | Class B Common Stock
Stockholders’ equity
Common stock value	148
As Restated
Balance Sheet
Total assets	59,328,581
Total current liabilities	198,291
Deferred underwriting commissions	2,012,500
Derivative warrant liabilities	15,776,805
Total liabilities	17,987,596
Class A common stock, $0.0001 par value; shares subject to possible redemption	36,340,978
Stockholders’ equity
Preferred stock- $0.0001 par value
Additional paid-in-capital	8,718,262
Accumulated deficit	(3,718,616)
Total stockholders’ equity	5,000,007
Total liabilities and stockholders’ equity	59,328,581
As Restated | Class B Common Stock
Stockholders’ equity
Common stock value	$ 217